130 related articles for article (PubMed ID: 7010898)
1. Sensitivity to exogenous insulin and release of endogenous insulin in hypopituitary non-hypoglycemic children treated with hGH.
Cicognani A; Salardi S; Mazzanti L; Cacciari E; Pirazzoli P; Zappulla F; Bernardi F; Bergamaschi R
Acta Paediatr Scand; 1981 Jan; 70(1):47-53. PubMed ID: 7010898
[No Abstract] [Full Text] [Related]
2. [Sensitivity to exogenous insulin and the efficiency and release of endogenous insulin in subjects with non-hypoglycemic hypopituitarism treated with growth hormone].
Cacciari E; Sarti E; Cicognani A; Pirazzoli P; Salardi S; Mazzanti L; Bernardi F; Zappulla F; Cassio A
Minerva Pediatr; 1980 Jan; 32(1):15-21. PubMed ID: 7019661
[No Abstract] [Full Text] [Related]
3. Hypopituitarism and diabetes mellitus: effect of human growth hormone.
Kogut MD; Donnell GN; Ling SM; Frasier SD
Pediatrics; 1968 May; 41(5):905-16. PubMed ID: 5654838
[No Abstract] [Full Text] [Related]
4. Effect of low-dose human growth hormone on carbohydrate metabolism in children with hypopituitarism.
Costin G; Kogut MD; Frasier SD
J Pediatr; 1972 May; 80(5):796-803. PubMed ID: 5018389
[No Abstract] [Full Text] [Related]
5. Growth hormone suppression of pancreatic polypeptide secretion.
Zipf WB; Kelch RP; Floyd JC; Hopwood NJ
J Clin Endocrinol Metab; 1981 Sep; 53(3):574-9. PubMed ID: 7021581
[No Abstract] [Full Text] [Related]
6. Metabolic changes and vascular risk factors in hypopituitarism.
Johnston DG; Beshyah SA; Markussis V; Shahi M; Sharp PS; Foale RA; Skinner EM
Horm Res; 1992; 38 Suppl 1():68-72. PubMed ID: 1295816
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell function in hypopituitary adults before and during growth hormone treatment.
Beshyah SA; Gelding SV; Andres C; Johnston DG; Gray IP
Clin Sci (Lond); 1995 Sep; 89(3):321-8. PubMed ID: 7493430
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia in hypopituitary children.
Hopwood NJ; Forsman PJ; Kenny FM; Drash AL
Am J Dis Child; 1975 Aug; 129(8):918-26. PubMed ID: 169689
[TBL] [Abstract][Full Text] [Related]
9. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism.
Krzyzanowska K; Schnack C; Mittermayer F; Kopp HP; Hofer M; Kann T; Schernthaner G
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):430-4. PubMed ID: 16151976
[TBL] [Abstract][Full Text] [Related]
11. Human placental lactogen and human growth hormone for hypopituitarism. Absence of growth potentiation.
Schutt-Aine JC; Drash AL
Am J Dis Child; 1972 May; 123(5):475-9. PubMed ID: 5026220
[No Abstract] [Full Text] [Related]
12. An unusual form of diabetes mellitus in ataxia telangiectasia.
Schalch DS; McFarlin DE; Barlow MH
N Engl J Med; 1970 Jun; 282(25):1396-402. PubMed ID: 4192270
[No Abstract] [Full Text] [Related]
13. Growth hormone replacement in a hypopituitary insulin dependent woman.
Lowy C
J Pediatr Endocrinol; 1993; 6(1):61-4. PubMed ID: 8374691
[No Abstract] [Full Text] [Related]
14. Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.
Jørgensen JO; Flyvbjerg A; Dinesen J; Lund H; Alberti KG; Orskov H; Christiansen JS
Acta Endocrinol (Copenh); 1987 Nov; 116(3):381-6. PubMed ID: 3318260
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive insulin (IRI) dynamics in GH-deficient patients following intravenous glycine loading.
Florea I; Popa M; Simionescu L; Ciovirnache M; Ionescu V
Endocrinologie; 1976; 14(4):291-5. PubMed ID: 1006134
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
Blethen SL; Daughaday WH; Weldon VV
J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood.
Bougneres PF; Artavia-Loria E; Ferre P; Chaussain JL; Job JC
J Clin Endocrinol Metab; 1985 Dec; 61(6):1152-7. PubMed ID: 3902870
[TBL] [Abstract][Full Text] [Related]
18. Effect of different human growth hormone preparations on nitrogen retention in hypopituitary children.
Butenandt O; Bidlingmaier F; Knorr D
Acta Paediatr Scand; 1974 Jul; 63(4):549-54. PubMed ID: 4851630
[No Abstract] [Full Text] [Related]
19. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
al-Shoumer KA; Gray R; Anyaoku V; Hughes C; Beshyah S; Richmond W; Johnston DG
Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
[TBL] [Abstract][Full Text] [Related]
20. Influence of long term growth hormone therapy on glucose tolerance and insulin secretion.
Zuppinger KA; Joss EE
Acta Paediatr Scand; 1971 Nov; 60(6):678-84. PubMed ID: 5123497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
